PaREnting ProgrAm to Enhance PREterm Infants' Health and Development (PREPARE Trial) (PREPARE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04783220 |
|
Recruitment Status :
Recruiting
First Posted : March 5, 2021
Last Update Posted : February 18, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Behavioral Assessment of Children Early Intervention | Behavioral: Comprehensive structured parent intervention | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 72 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Supportive Care |
| Official Title: | Comprehensive PaREnting ProgrAm to Enhance PREterm Infants' Health and Development: A Randomized Controlled Trial (PREPARE Trial) |
| Actual Study Start Date : | November 1, 2021 |
| Estimated Primary Completion Date : | January 30, 2023 |
| Estimated Study Completion Date : | January 30, 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention
The parents of babies in this group will receive an educational and intervention program
|
Behavioral: Comprehensive structured parent intervention
|
|
No Intervention: Control
The parents of babies in this group will receive the standard parent education and follow-up.
|
- Child developmental outcome [ Time Frame: 9 months ]
The developmental outcome of preterm children will be assessed using the Ages and Stages Questionnaire at 9 months of corrected age.
The ASQ-3 covers 5 area of child development : Gross Motor, Fine Motor, Problem Solving, Personal-Social, Communication.
Scores for each area should range between minimum 0 and maximum 60. Higher scores indicate that the child is developing properly.
- Physiological state- Respiratory rate [ Time Frame: 1 year ]Physiological parameters including respiratory rate will be retrieved from the bedside monitors.
- Physiological state - Oxygen saturation [ Time Frame: 1 year ]Physiological parameters including oxygen saturation will be retrieved from the bedside monitors.
- Neurobehavioral state [ Time Frame: 1 year ]Behavioral state will be assessed by a cerified trained developmental specialist using a 7-point score that include: (i) Quiet/deep sleep, (ii) Active sleep, (iii) Awake State, (iv) drowsy, (v) quiet alert, (vi) active alert, (vii) crying
- Parental Knowledge assessment [ Time Frame: Before hospital discharge ]Parental knowledge assessment test will be administered before and after the education sessions using 10 true/false questions regarding topics addressed in the sessions.
- Parental stress [ Time Frame: 1 year ]
The Arabic parenting stress index short form questionnaire will be used. The PSI-SF is a self-administered questionnaire and consists of 36 items divided into three subscales of 12 items each: parental distress, parent-child dysfunctional interaction and difficult child.
For each subscales scores ranges should be between 12 and 60. For the total stress score , the minimum score is 36 and the maximum is 180. Higher scores mean more depressive symptoms.
- Behavioral parenting activities [ Time Frame: 1 year ]A questionnaire derived from the UNICEF MICS 6 questionnaire will be used. MICS or "MULTIPLE INDICATOR CLUSTER SURVEY" is a tool used to assess the activities of parents with their infants.
- Parents perceptions [ Time Frame: 1 year ]
The Perceived Maternal Parenting Self-Efficacy questionnaire is a standardized valid and reliable instrument to assess parent's perceptions of their ability to care for their infants.
PMP-SE is composed of 20 items divided into four subscales: care taking procedures, evoking behaviours, reading behaviours or signalling, and situational beliefs.
Those items are formulated as statements using a five-point Likert scale. Scoring ranges from 20 to 80 where a higher score indicates a higher self-efficacy.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | up to 21 Days (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Couplets of parents and their preterm infants admitted to the NICU, who are <35 weeks gestation at birth and who are deemed medically stable by their treating neonatologist.
Exclusion Criteria:
- Infants with significant neurologic disorder precluding meaningful interaction with the parents as determined by the neurologist
- Infants with major congenital anomalies precluding meaningful interaction with the parents as determined by the neurologist
- Infants with systemic medical and/ or surgical conditions precluding interaction with the parents, other than preterm-related intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL).
- Parental refusal to participate
- Absence of clearance from the neonatologist
- Infants planned to be transferred to another facility for their NICU care.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04783220
| Contact: Lama Charafeddine, MD | 009611350000 ext 5874 | lc12@aub.edu.lb |
| Lebanon | |
| American University of Beirut | Recruiting |
| Beirut, Hamra, Lebanon, 1107 2020 | |
| Contact: Lama Charafeddine, MD 009611350000 ext 5874 lc12@aub.edu.lb | |
| Principal Investigator: | Lama Charafeddine, MD | American University of Beirut Medical Center |
| Responsible Party: | American University of Beirut Medical Center |
| ClinicalTrials.gov Identifier: | NCT04783220 |
| Other Study ID Numbers: |
SBS-2020-0365 |
| First Posted: | March 5, 2021 Key Record Dates |
| Last Update Posted: | February 18, 2022 |
| Last Verified: | January 2022 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Preterm infant Parental stress Early child development Parenting in the neonatal intensive care |
|
Premature Birth Obstetric Labor, Premature Obstetric Labor Complications Pregnancy Complications |

